
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp demonstrates a positive financial outlook, supported by an expected 2.6% increase in Medicare Hospice rates effective October 2025, which may enhance revenue for its Hospice segment. The company's impressive organic revenue growth rates, showcasing +12.3% year-over-year in 2023, +7.7% in 2024, and +7.4% year-to-date in 2025, indicate robust demand for its personal care services in a post-pandemic environment. Additionally, anticipated growth in the Hospice segment, projected at +5% to +7%, alongside potential merger and acquisition activities, signals further opportunities for revenue expansion and operational improvements.
Bears say
Addus HomeCare Corp faces a negative outlook primarily due to same-store declines driven by administrative bottlenecks related to Medicaid redeterminations, resulting in higher patient discharges compared to admissions. Approximately 97% of the company's segment revenues for 2025 year-to-date stem from the uncertain future of Medicaid funding, particularly in light of the legislative impacts from the One Big Beautiful Bill Act (OBBBA). Despite stable operational execution and a favorable long-term demand backdrop, the company's stock has not kept pace with the broader post-acute care sector, indicating a disconnect between equity valuation and the fundamental challenges it faces.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares